Towards individualized cancer therapy: Challenges and prospects
- 26 December 2013
- journal article
- Published by Wiley in Molecular Oncology
- Vol. 8 (1), 1-8
- https://doi.org/10.1016/j.molonc.2013.12.008
Abstract
At the 17th International Symposium in the annual series of prestigious meetings organized by the Fritz Bender Foundation, 07–09 November 2013, researchers, clinicians and students gathered to discuss and exchange knowledge on individualized cancer therapies. Co‐organized and hosted by the Vall d'Hebron Institute of Oncology (VHIO), Barcelona, Spain, the sessions covered genetic profiling of patients, tumor characterization, tumor–host relationships and therapeutic targets, with talks from many international experts in the field. The presentations summarized in this report illustrate the current status of our knowledge and the future directions for cancer research in these broad topic areas.Keywords
Funding Information
- Fritz-Bender-Stiftung
- “la Caixa” Foundation
This publication has 18 references indexed in Scilit:
- A melanocyte lineage program confers resistance to MAP kinase pathway inhibitionNature, 2013
- Genome-Wide Association Study in BRCA1 Mutation Carriers Identifies Novel Loci Associated with Breast and Ovarian Cancer RiskPLoS Genetics, 2013
- Highly Recurrent TERT Promoter Mutations in Human MelanomaScience, 2013
- Role of Macrophage Targeting in the Antitumor Activity of TrabectedinCancer Cell, 2013
- Constitutive HER2 Signaling Promotes Breast Cancer Metastasis through Cellular SenescenceCancer Research, 2013
- PI3K Inhibition Impairs BRCA1/2 Expression and Sensitizes BRCA-Proficient Triple-Negative Breast Cancer to PARP InhibitionCancer Discovery, 2012
- Molecular Profiling of Patients with Colorectal Cancer and Matched Targeted Therapy in Phase I Clinical TrialsMolecular Cancer Therapeutics, 2012
- The genomic and transcriptomic architecture of 2,000 breast tumours reveals novel subgroupsNature, 2012
- USP15 stabilizes TGF-β receptor I and promotes oncogenesis through the activation of TGF-β signaling in glioblastomaNature Medicine, 2012
- Regression of melanoma metastases after immunotherapy is associated with activation of antigen presentation and interferon‐mediated rejection genesInternational Journal of Cancer, 2011